The HPRA advises healthcare professionals not to retain printed versions of Summary of Product Characteristics (SPC) documents. As these documents are subject to frequent content updates, including changes to safety and dose related information, we recommend that you visit our website as necessary to access the most up-to-date versions. If you have any queries about specific SPCs on our website then please e-mail

ZYDOL SR 150 mg prolonged-release tablets

150 milligram(s) Prolonged-release tablet

Grunenthal Pharma LtdPA2242/005/004

Main Information

Trade NameZYDOL SR 150 mg prolonged-release tablets
Active SubstancesTramadol hydrochloride
Strength150 milligram(s)
Dosage FormProlonged-release tablet
Licence HolderGrunenthal Pharma Ltd
Licence NumberPA2242/005/004

Group Information

ATC CodeN02AX Other opioids
N02AX02 tramadol


Licence Issued21/02/1997
Legal statusProduct subject to prescription which may be renewed (B)
Supply StatusSupply through pharmacies only
Advertising StatusAdvertising to healthcare professionals only
Conditions of Licence
Marketing StatusMarketed


Summary of Product CharacteristicsPDF Version
Package LeafletPDF Version
Public Assessment ReportNo document available

Generics Information

Interchangeable List CodeIC0074-062-030
Interchangeable List DocumentPDF of Interchangeable List
« Back